Alzheimer's Care


Alzheimer's Care: learn more about the different forms of diseases, current research, drugs, treatment, therapies and care.Memantine.com | Alzheimer's Care: Here you get information about forms of diseases, drugs, therapies, care and latest research results. Alzheimer's Care Merz GmbHAlzheimer's Care Merz - our research for your health. The excitatory effect of chronically released glutamate effects the degeneration of cortical and subcortical neurons, thus leading to the occurrence of dementia symptoms. Alzheimer's Care: learn more about the different forms of diseases, current research, drugs, treatment, therapies and care. Alzheimer's Care is a topic that anyone of us should think about, because when growing old, everyone could be affected. Inform yourself about Alzheimer's Care now! The care for elderly people and their diseases are a topic for our society, whose importance grows each day. That's why we at Merz take Alzheimer's Care very serious, so that we can offer you the best drug for each treatment and therapy you need. Alzheimer's Care and Merz means research for your health. High-quality products and information about Alzheimer's Care can be found on our website. Visit us online and learn everything about Alzheimer's Care from one of Germany's leading health care companies. Our contribution to Alzheimer's Care: read here what we can do for you. Further links: Axura: Information for professionals.>>>  Alzheimer's Care Merz GmbH Memantine.com | Alzheimer's Care: Here you get information about forms of diseases, drugs, therapies, care and latest research results. That's why we at Merz take Alzheimer's Care very serious, so that we can offer you the best drug for each treatment and therapy you need. Alzheimer's Care Merz GmbHAlzheimer's CareThe excitatory effect of chronically released glutamate effects the degeneration of cortical and subcortical neurons, thus leading to the occurrence of dementia symptoms.Memantine.com | Alzheimer's Care: Here you get information about forms of diseases, drugs, therapies, care and latest research results. Memantine , Alzheimer's Treatment . Calcium enters into the cell, and through secondary processes, the signal is recognized. Such excitotoxicity ultimately leads to neuronal calcium overload and has been implicated in neurodegenerative disorders. Senile Dementia , Dementia Care . A signal is produced which due to the lower noise can be recognized and processed which leads to a symptomatic improvement in dementia symptoms. The starting point is the pathological release of glutamate, followed by elevated calcium concentrations. Alzheimer's Research , Alzheimer . Recent results from a Phase III trial show that patients receiving a combination of memantine and donepezil performed significantly better than patients receiving donepezil and placebo. At the same time, Memantine reduces caregiver time by more than 50 hours a month. A signal is produced which due to the lower noise can be recognized and processed which leads to a symptomatic improvement in dementia symptoms. Demenzkranke , Verwirrtheit Gedächtnisstörungen Short Term Memory Loss Symptoms Of Alzheimer's Disease . Merz Pharmaceuticals, as a member of Merz Pharma, is an innovative and international healthcare company, specializing in the research, development and marketing of pharmaceuticals for the treatment of neurological and psychiatric diseases. Alzheimer Erkrankung , Symptoms Of Alzheimer's Alzheimer's Disease Symptoms . The intracellular calcium pool is reduced, and the noise lower. The excitatory neurotransmitter glutamate plays an important part in the development of neurodegenerative diseases like dementia. Memantine improves cognitive and psychomotor functioning, activities in daily living and the clinical global impression. Glutamate is the principal neurotransmitter in the brain. In studies of memantine, doctors assessed tolerability as good or very good in 93 percent of patients. Alzheimer's Drug Dementia Symptoms , Hirnleistungsstörungen . The starting point is the pathological release of glutamate, followed by elevated calcium concentrations. Memantine is a NMDA receptor antagonist and protects the glutamatergic system from pathological activation. Clinically-relevant doses of memantine produce improvements in learning under conditions of tonic NMDA receptor activation in Alzheimer's disease. Merz Pharmaceuticals, as a member of Merz Pharma, is an innovative and international healthcare company, specializing in the research, development and marketing of pharmaceuticals for the treatment of neurological and psychiatric diseases. Demenz Krankheit Alzheimer Behandlung NMDA-Schutz Demenz Früherkennung , Mild Cognitive Impairment Altersdemenz . A signal is produced which due to the lower noise can be recognized and processed which leads to a symptomatic improvement in dementia symptoms. There is a continuous influx of calcium into the cell, increasing the calcium pool. As memantine, in contrast to magnesium, blocks the NMDA receptor in the presence of sustained release of low glutamate concentrations, the influx of calcium is prevented (neuroprotection). Glutamate stimulates a number of postsynaptic receptors, including the N-methyl-D-aspartate (NMDA) receptor, which has been particularly implicated in memory processes, dementia, and the pathogenesis of Alzheimer's disease. Under physiological conditions, the NMDA receptor is blocked by magnesium ions, thereby protecting the neuron against glutamatergic excitotoxicity. Other franchise covered by Merz are hepatology, metabolic diseases and dermatology. Memantine is a NMDA receptor antagonist and protects the glutamatergic system from pathological activation. Clinically-relevant doses of memantine produce improvements in learning under conditions of tonic NMDA receptor activation in Alzheimer's disease. The safety of the combination therapy was investigated in a postmarketing surveillance study. Such excitotoxicity ultimately leads to neuronal calcium overload and has been implicated in neurodegenerative disorders. Due to its strong voltage-dependency, magnesium leaves the NMDA receptor. Merz Pharmaceuticals, as a member of Merz Pharma, is an innovative and international healthcare company, specializing in the research, development and marketing of pharmaceuticals for the treatment of neurological and psychiatric diseases. The safety of the combination therapy was investigated in a postmarketing surveillance study. Alzheimer und Demenz , Glutamate Demenz Behandlung Demenz-Erkrankung . Merz is a leader in the field of Alzheimer research and developed the first drug for the treatment of moderate to severe Alzheimer s. Memantine improves cognitive and psychomotor functioning, activities in daily living and the clinical global impression. Alzheimer's Disease Alzheimer Therapie , Symptoms Of Dementia . A significant improvement in cognitive performance is seen during treatment with the NMDA antagonist, especially when only small vessels are affected. NMDA-Antagonist Forgetfulness , Glutamat Alzheimer Früherkennung . Calcium enters into the cell, and through secondary processes, the signal is recognized. vaskuläre Demenz , Lewy Body Dementia Demenz Therapie Vascular Dementia . Memantine is a NMDA receptor antagonist and protects the glutamatergic system from pathological activation. Clinically-relevant doses of memantine produce improvements in learning under conditions of tonic NMDA receptor activation in Alzheimer's disease. Gedächtnis , Demenz . Merz , Multi Infarct Dementia . Alzheimer's Dementia Axura , Vergesslichkeit Antidementiva Alzheimer's Caregiver . Stages Of Alzheimer's Disease , Akatinol Alzheimer's Support Hirnleistungsstörung NMDA-Protection . This is clearly discernible behind the low background noise. Due to its strong voltage-dependency, magnesium leaves the NMDA receptor. Alzheimer's , Demenzerkrankung Dementia . Merz is a leader in the field of Alzheimer research and developed the first drug for the treatment of moderate to severe Alzheimer s. Memory Loss Pseudodemenz Alzheimer's Care , Dementia Treatment . Therefore memantine has a low potential for day-day interactions in these multimorbid patients. Memantine is the first representative of a new class of Alzheimer drugs, a moderate affinity NMDA-receptor antagonist. Dementia And Alzheimer's Alzheimer Krankheit , Demenzkrank . Alzheimer's Symptoms , Mental Confusion . Memantine improves cognitive and psychomotor functioning, activities in daily living and the clinical global impression. Glutamate is the principal neurotransmitter in the brain. Dementia Medication Literatur , Erkennung Diagnose Studien . Memantine is well tolerated even in long-term therapy. Memantine is well tolerated even in long-term therapy. Medikamentkombinationen , Demenz Medikament . Therapy , Help . Diagnosis , Information Literature . Studies , Combination . Treatment Alzheimer's Therapie Demenz Alzheimer Medikament , Medication Alzheimer's . Alzheimer's Care Merz - our research for your health. Alzheimer's Care
Merz Logo
Merz
Merz visuell
 


This page has moved permanently. You will be redirected to our new website. If not, your browser does not support JavaScript. Please activate JavaScript. Details below.

>> Start >>


Microsoft Internet Explorer (version 5.0 and later)
Open the menu "Tools", choose "Internet options" and go to the tab "Security". Then click on the button "Custom Level" and scroll down to the setting "Active Scripting" and select "Activate".


Netscape Navigator (version 4.7 and later)
In the "Edit"-menu choose the item "preferences". Open the item "Extended" and activate the control button "activate JavaScript".

 
Merz GmbH Alzheimer's CareAlzheimer's Care Merz - our research for your health. Alzheimer's Care Alzheimer's Care Merz - our research for your health. Alzheimer's Care is a topic that anyone of us should think about, because when growing old, everyone could be affected.